Covered recipient · General Payments record
CANDICE WAITH
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,202.19
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $251.19 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $72.22 | 4 |
| Acerta Pharma LLC | $70.31 | 4 |
| Lilly USA, LLC | $65.29 | 3 |
| Amgen Inc. | $21.94 | 1 |
| ABBVIE INC. | $21.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.43 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108369825 | CMS |
| Amgen Inc. | $21.94 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711971 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.17 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105341028 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.35 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104733301 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.69 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105772600 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.10 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105564488 | CMS |
| Lilly USA, LLC | $24.52 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135581702 | CMS |
| Lilly USA, LLC | $22.28 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135554732 | CMS |
| Lilly USA, LLC | $18.49 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135581704 | CMS |
| Novo Nordisk Inc | $13.71 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100268152 | CMS |
| Novo Nordisk Inc | $18.23 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100397504 | CMS |
| Novo Nordisk Inc | $21.77 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100502617 | CMS |
| Novo Nordisk Inc | $18.51 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130818474 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.